Language:
  
[Sign in] [Register]   

EIAab logo

Index > Protein center > FHIT(Gene name) > Human
  • Add your favorite
  • FHIT (Gene name),
  • Bis(5'-adenosyl)-triphosphatase (Protein name ),  FHIT_HUMAN from NCBI database.
  • top
  • Come back to page head.
  • |
  • General Annotation
  • |
  • Antigen Annotation
  • |
  • 3D
  • |
  • Predicted Eptitope
  • |
  • Vaild Sequence
  • |
  • Related Databases
  • |
  • Feedback
  • Gene name:
    FHIT;
    Protein name:
    Bis(5'-adenosyl)-triphosphatase;
    Alternative:
    Diadenosine 5',5'''-P1,P3-triphosphate hydrolase;AP3A hydrolase(AP3Aase);Fragile histidine triad protein;Dinucleosidetriphosphatase;
    Organism:
    Human (Homo sapiens). 
    General Annotation
    Sub Unit:
    Homodimer.
    Function:
    Cleaves A-5'-PPP-5'A to yield AMP and ADP. Possible tumor suppressor for specific tissues.
    Subcellular Location:
    Cytoplasm
    Protein Attributes:
    Sequence length:
    147
    Sequence:
    50:
    MSFRFGQHLI | KPSVVFLKTE | LSFALVNRKP | VVPGHVLVCP | LRPVERFHDL | 
    100:
    RPDEVADLFQ | TTQRVGTVVE | KHFHGTSLTF | SMQDGPEAGQ | TVKHVHVHVL | 
    147:
    PRKAGDFHRN | DSIYEELQKH | DKEDFPASWR | SEEEMAAEAA | ALRVYFQ
    3D Structure:
    N/A
    Predicted Eptitope:
    Please Sign in.
    EIAab Sequence  Vaild Sequence:
    Please Sign in.
    Related Databases
    MIM:
    SMR:
    KEGG:
    UniGene:
    String:
    Pfam:
    Uniprot:
     
    FOR
    ELISA Kit for Human Bis(5'-adenosyl)-triphosphatase
    ELISA Kit for Human Bis(5'-adenosyl)-triphosphatase
    ELISA Kit for Human Bis(5'-adenosyl)-triphosphatase
    ELISA Kit for Human Bis(5'-adenosyl)-triphosphatase
    CLIA Kit for Human Bis(5'-adenosyl)-triphosphatase
    CLIA Kit for Human Bis(5'-adenosyl)-triphosphatase
    CLIA Kit for Human Bis(5'-adenosyl)-triphosphatase
    CLIA Kit for Human Bis(5'-adenosyl)-triphosphatase
    Polyclonal Antibody for Human Bis(5'-adenosyl)-triphosphatase
    Polyclonal Antibody for Human Bis(5'-adenosyl)-triphosphatase
    Polyclonal Antibody for Human Bis(5'-adenosyl)-triphosphatase
    Polyclonal Antibody for Human Bis(5'-adenosyl)-triphosphatase
    Monoclonal Antibody for Human Bis(5'-adenosyl)-triphosphatase
    Monoclonal Antibody for Human Bis(5'-adenosyl)-triphosphatase
    Monoclonal Antibody for Human Bis(5'-adenosyl)-triphosphatase
    Monoclonal Antibody for Human Bis(5'-adenosyl)-triphosphatase
    Protein for Human Bis(5'-adenosyl)-triphosphatase
    Protein for Human Bis(5'-adenosyl)-triphosphatase
    Protein for Human Bis(5'-adenosyl)-triphosphatase
    Protein for Human Bis(5'-adenosyl)-triphosphatase

    R&D Technical Data
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Precision
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Recovery
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Linearity
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    References
    1. 1.
      "The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers."
      Ohta M. , Inoue H. , Cotticelli M.G. , Kastury K. , Baffa R. , Palazzo J. , Siprashvili Z. , Mori M. , McCue P. , Druck T. , Croce C.M. , Huebner K.
      Cell84:587-597(1996) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA]
    2. 2.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]
    3. 3.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA]
    4. 4.
      "Mutational analysis of FHIT gene."
      Naqvi S.R.A. , Malik A. , Kukreti H. , Chaudhary A. , Anand R. , Deo S.S. , Shukla N.K. , Husain S.A. , Pasha S.T.
      Submitted (2005-07) to the EMBL/GenBank/DDBJ databases
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA];NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 94-146
    5. 5.
      "Complete sequencing and characterization of 21,243 full-length human cDNAs."
      Ota T. , Suzuki Y. , Nishikawa T. , Otsuki T. , Sugiyama T. , Irie R. , Wakamatsu A. , Hayashi K. , Sato H. , Nagai K. , Kimura K. , Makita H. , Sekine M. , Obayashi M. , Nishi T. , Shibahara T. , Tanaka T. , Ishii S. , more...
      Nat. Genet.36:40-45(2004) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]
      tissue: Brain.
    6. 6.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]
    7. 7.
      "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."
      The MGC Project Team
      Genome Res.14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]
      tissue: Colon.
    8. 8.
      "Fhit, a putative tumor suppressor in humans, is a dinucleoside 5',5''-P1,P3-triphosphate hydrolase."
      Barnes L.D. , Garrison P.N. , Siprashvili Z. , Guranowski A. , Robinson A.K. , Ingram S.W. , Croce C.M. , Ohta M. , Huebner K.
      Biochemistry35:11529-11535(1996) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: FUNCTION;CATALYTIC ACTIVITY;MUTAGENESIS OF HIS-35; HIS-94; HIS-96 AND HIS-98
    9. 9.
      "The hereditary renal cell carcinoma 3;8 translocation fuses FHIT to a patched-related gene, TRC8."
      Gemmill R.M. , West J.D. , Boldog F. , Tanaka N. , Robinson L.J. , Smith D.I. , Li F. , Drabkin H.A.
      Proc. Natl. Acad. Sci. U.S.A.95:9572-9577(1998) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: CHROMOSOMAL TRANSLOCATION WITH RNF139
    10. 10.
      "Association of FHIT (fragile histidine triad), a candidate tumour suppressor gene, with the ubiquitin-conjugating enzyme hUBC9."
      Shi Y. , Zou M. , Farid N.R. , Paterson M.C.
      Biochem. J.352:443-448(2000) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: INTERACTION WITH UBE2I
    11. 11.
      "Designed FHIT alleles establish that Fhit-induced apoptosis in cancer cells is limited by substrate binding."
      Trapasso F. , Krakowiak A. , Cesari R. , Arkles J. , Yendamuri S. , Ishii H. , Vecchione A. , Kuroki T. , Bieganowski P. , Pace H.C. , Huebner K. , Croce C.M. , Brenner C.
      Proc. Natl. Acad. Sci. U.S.A.100:1592-1597(2003) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: FUNCTION;CATALYTIC ACTIVITY;MUTAGENESIS OF ILE-10; LEU-25 AND HIS-96
    12. 12.
      "The mechanism of action of the fragile histidine triad, Fhit: isolation of a covalent adenylyl enzyme and chemical rescue of H96G-Fhit."
      Huang K. , Arabshahi A. , Wei Y. , Frey P.A.
      Biochemistry43:7637-7642(2004) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: ACTIVE SITE;CATALYTIC ACTIVITY;MUTAGENESIS OF HIS-96
    13. 13.
      "Synergistic tumor suppression by coexpression of FHIT and p53 coincides with FHIT-mediated MDM2 inactivation and p53 stabilization in human non-small cell lung cancer cells."
      Nishizaki M. , Sasaki J. , Fang B. , Atkinson E.N. , Minna J.D. , Roth J.A. , Ji L.
      Cancer Res.64:5745-5752(2004) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: FUNCTION;SUBCELLULAR LOCATION;INTERACTION WITH MDM2
    14. 14.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: PHOSPHORYLATION BY SRC;SUBUNIT;SUBCELLULAR LOCATION;MASS SPECTROMETRY;DISEASE;PHOSPHORYLATION AT TYR-114 AND TYR-145;MUTAGENESIS OF TYR-114 AND TYR-145
    15. 15.
      "Fhit modulation of the Akt-survivin pathway in lung cancer cells: Fhit-tyrosine 114 (Y114) is essential."
      Semba S. , Trapasso F. , Fabbri M. , McCorkell K.A. , Volinia S. , Druck T. , Iliopoulos D. , Pekarsky Y. , Ishii H. , Garrison P.N. , Barnes L.D. , Croce C.M. , Huebner K.
      Oncogene25:2860-2872(2006) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: MUTAGENESIS OF TYR-114;FUNCTION
    16. 16.
      "The tumor suppressor Fhit acts as a repressor of beta-catenin transcriptional activity."
      Weiske J. , Albring K.F. , Huber O.
      Proc. Natl. Acad. Sci. U.S.A.104:20344-20349(2007) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: INTERACTION WITH CTNNB1;IDENTIFICATION IN A COMPLEX WITH CTNNB1 AND LEF1;FUNCTION
    17. 17.
      "Intramitochondrial calcium regulation by the FHIT gene product sensitizes to apoptosis."
      Rimessi A. , Marchi S. , Fotino C. , Romagnoli A. , Huebner K. , Croce C.M. , Pinton P. , Rizzuto R.
      Proc. Natl. Acad. Sci. U.S.A.106:12753-12758(2009) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: SUBCELLULAR LOCATION;FUNCTION IN APOPTOSIS
    18. 18.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
    19. 19.
      "MAD analysis of FHIT, a putative human tumor suppressor from the HIT protein family."
      Lima C.D. , D'Amico K.L. , Naday I. , Rosenbaum G. , Westbrook E.M. , Hendrickson W.A.
      Structure5:763-774(1997) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: X-RAY CRYSTALLOGRAPHY (1.85 ANGSTROMS)
    20. 20.
      "Structure-based analysis of catalysis and substrate definition in the HIT protein family."
      Lima C.D. , Klein M.G. , Hendrickson W.A.
      Science278:286-290(1997) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) IN COMPLEXES WITH SUBSTRATES;CATALYTIC ACTIVITY;FUNCTION;SUBUNIT;ACTIVE SITE;ABSENCE OF METAL COFACTOR
    21. 21.
      "Genetic, biochemical, and crystallographic characterization of Fhit-substrate complexes as the active signaling form of Fhit."
      Pace H.C. , Garrison P.N. , Robinson A.K. , Barnes L.D. , Draganescu A. , Roesler A. , Blackburn G.M. , Siprashvili Z. , Croce C.M. , Huebner K. , Brenner C.
      Proc. Natl. Acad. Sci. U.S.A.95:5484-5489(1998) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) IN COMPLEXES WITH SUBSTRATE ANALOGS;SUBUNIT;CATALYTIC ACTIVITY;COFACTOR;MUTAGENESIS OF HIS-96
    Product Feedback Wall
    Hot Genes
    Atf2 ASPRO ACE ALCAM C19orf80 Trap1a Gdf5
    Top Searches
    Ubiquitin-protein ligase metalloproteinase Ubiquitin ELISA Alpha Tumor necrosis Asprosin TRAP1A
    Why choose EIAAB
    Our products have been quoted by many publications in famous journals such as Cell; Cell Metabolism; Hepatology; Biomaterials.more
    Further Information
    About us Protein center Bank account Distributors Terms & Conditions Career eiaab.com.cn

    Copyright & copy www.eiaab.com2006-2016 All Rights Reserved    EIAab         Email:eiaab@eiaab.com

    鄂ICP备10015095号-1

    鄂公网安备 42018502005535号

    Twitter